Research from University of Munich Provides New Study Findings on Breast Cancer (Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast ...)

Source :: Women's Health Weekly. October 28, 2021, 663
Publication Year :: 2021
Abstract: 2021 OCT 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on breast cancer. According to news originating from Munich, Germany, [...]

Subjects :: Bayer AG -- Product development
Oncology, Experimental -- Reports
Women -- Health aspects
Cancer -- Adjuvant treatment -- Research
Clinical trials -- Reports -- Research
Breast cancer -- Research
Biological markers -- Reports -- Research
Pharmaceutical industry -- Product development
Health
Women's issues/gender studies
University of Munich -- Reports

Tools